Cervical cancer in a reference unit in Maranhão state, Brazil
epidemiological profile and staging at the time of diagnosis
DOI:
https://doi.org/10.47456/rbps.v27i1.46313Keywords:
Women’s Health, Cervical Cancer, Oncology NursingAbstract
Introduction: Cervical cancer (CC) is caused by the Human Papillomavirus (HPV) and can be defined as the uncontrolled multiplication of the cells of the uterine epithelium, potentially compromising underlying tissues such as organs and other structures. Objective: To describe the epidemiological profile and lesion staging of women affected by cervical cancer in Maranhão. Methods: Descriptive, cross-sectional study using secondary data from the Hospital Cancer Registry Health Information System, from January 1 to December 31, 2022. Results: Of the 464 women diagnosed with cervical cancer, there was a predominance of the 33–47 age group. Regarding origin, the highest prevalence was found in the state capital, São Luís, Maranhão, with 161 records (34.70%). As for the staging of cervical cancer lesions, the highest number was found at stage IIIB, with 103 records (22.20%). Conclusion: The findings show that, in the referral unit studied, women were predominantly diagnosed at advanced stages of the disease, especially at stage IIIB. These results highlight weaknesses in screening, early detection, and timely access to health services, reinforcing the urgent need to strengthen public policies aimed at expanding cytological screening coverage and broadening access to primary care services.
Downloads
References
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019.
Organização Pan-Americana da Saúde. HPV e câncer do colo do útero [Internet]. Washington: OPAS; 2021 [citado 2021 maio 10]. Disponível em: https://www.paho.org/pt/topicos/hpv-e-cancer-do-colo-do-utero
Stumbar SE, Stevens M, Feld Z. Cervical cancer and its precursors. Prim Care. 2019;46(1):117-34.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Conceito e magnitude. Rio de Janeiro: INCA; 2020.
Kurebayashi JMY, et al. Rastreamento das atipias celulares de colo de útero em mulheres na atenção primária. Rev Bras Enferm. 2020;73 Suppl 4:e20190251.
Fernandes DMA, Carvalho ATD, Melo VFCDE. Câncer de colo uterino avançado e o cuidado longitudinal na atenção básica. Braz J Health Rev. 2020;3(5):15237-42.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: incidência do câncer no Brasil. Rio de Janeiro: INCA; 2022.
Fundação Antonio Dino. Hospital do Câncer Aldenora Bello [Internet]. São Luís: Fundação Antonio Dino; 2021 [citado 2021 maio 19]. Disponível em: https://fundacaoantoniodino.org.br/hospitalaldenorabello/
Instituto Brasileiro de Geografia e Estatística. Censo demográfico 2022: população e domicílios — resultados preliminares [Internet]. Rio de Janeiro: IBGE; 2023 [citado 2024 mar 23]. Disponível em: https://censo2022.ibge.gov.br/
Pimenta GM, Dutra GV, Pinheiro ALLP. Perfil epidemiológico das mulheres com diagnóstico de câncer de colo uterino em região de alta incidência do norte do país no período de 2014-2018. Rev Interdiscip Saúde. 2021;8:391-401.
Pedrosa TFM, Magalhães SD, Peres AL. Profile of women with cervical changes from a city in the Northeast Brazil. J Bras Patol Med Lab. 2019;55(1):32-43.
Pinheiro ALLP. Perfil clínico e epidemiológico de mulheres com câncer de colo uterino no Norte do Estado do Tocantins durante o período de 2000 a 2015 [dissertação]. São Paulo: Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP; 2021.
Gerolin Donaire B, Souza SMP, Giorgi LPCV, Souza NMP. Avaliação do perfil epidemiológico de pacientes com diagnóstico de carcinoma invasor de colo uterino. Health Residencies J. 2021;2(10):48-66.
Barros SA, et al. Perfil epidemiológico dos casos de câncer do colo uterino no estado de Sergipe. Rev Eletrônica Acervo Saúde. 2022;15(4):e10043.
Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios Contínua — PNAD 2020-2021. Rio de Janeiro: IBGE; 2022.
Lima KF, Melo LHCP, Gomes LM, Rodrigues-Antunes S, Feio DCA. A importância dos fatores associados à não adesão ao exame preventivo do câncer de colo uterino por mulheres brasileiras: revisão sistemática. Rev Bras Anal Clin. 2022;54(1):55-61.
Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios — PNAD 2019. Brasília: IBGE; 2019.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. 2ª ed. rev. atual. Rio de Janeiro: INCA; 2016.
Passos SD, Jardim PT. Perfil epidemiológico das mulheres com câncer invasivo de colo uterino atendidas em serviço de referência de Campo Grande-MS. Anais do ENIC. 2018;1(10).
Bento AGM, Silva ACMS, Bichoff GB, Ribeiro GT, Gomes JC, Oliveira LR, et al. Fatores de risco comportamentais para o câncer de colo uterino. In: Promoção e proteção da saúde da mulher, ATM 2026/1. Porto Alegre: Universidade Federal do Rio Grande do Sul, Faculdade de Medicina; 2023. p. 69-82.
Pereira JDS, et al. Tecnologia no cuidado como instrumento de diagnóstico do câncer no colo do útero: um relato de experiência. Rev Eletrônica Acervo Saúde. 2020;(42):e2260.
Bezerra WBS, Nascimento PP, Sampaio SSC. Perfil epidemiológico do câncer do colo do útero no estado do Piauí. Res Soc Dev. 2021;10(13):e182101321085.
Queiroz A, Said P, Carvalho R, Maria S, Almeida ACG, Brito MAM. Frequency, treatment and staging of cervical cancer cases in the northern region of Brazil between the years 2017 to 2021. Res Soc Dev. 2023;12(6):e7012641900.
Silva LCG, Moreira WPE, Lopes APRM. Análise epidemiológica do câncer de colo do útero no estado do Tocantins no período de 2015 a 2018. Facit Bus Technol J. 2021;2(31):246-58.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Eliane da Silva Alencar, Bruna da Silva Falcão, Vanessa Moreira da Silva Soeiro, Larissa Di Leo Nogueira Costa
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
